Grenke AG (GLJ)
XETRA Stock Exchange · Germany · prices in EUR · close of 23 Oct 2026
Key indicators
| Last close | EUR 9.920 |
|---|---|
| 52-week range | 9.730 – 16.080 |
| Return, 1 month / 3 months | −9.5% / −14.6% |
| Return, 1 year / 3 years | −35.2% / −45.1% |
| Trend | Below its 200-day average |
| RSI (14) | 35 |
| Volatility (1 year) | 30.6% |
| Worst drawdown (1 year) | -37.1% |
| Average daily value traded | 1.23M EUR |
| Dividend yield | 4.2% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Grenke AG is a German financial services company based in Baden-Baden that specialises in leasing and financing for small and medium-sized businesses. It offers leasing of office equipment, information technology, printing and copying systems, and other business equipment, along with factoring services that help firms manage their invoices and cash flow. The company serves tradespeople, retailers and professional firms, and it operates through its own banking arm, which supports its lending and leasing activities.
On this site Grenke AG appears as a stock on the XETRA Stock Exchange (Germany), code GLJ, with prices in euros (EUR). Our dividend records, which start in 2019, show payments in 8 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Grenke AG (GLJ) trades on the XETRA Stock Exchange in Germany. It last closed at EUR 9.920 on 23 October 2026.
Its price-based Market X-Ray is 40 out of 100 (a weak price profile), ranking 484 of 701 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price fell 35.2% and over the last three months it fell 14.6%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on XETRA Stock Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 20 · Weak | Below its long-term averages and far from its highs. | |
| Above 200-day average | -19.7% | ||
| From 52-week high | -38.2% | ||
| Momentum | 20 · Weak | Lagging most stocks on this exchange. | |
| 3-month return | -14.6% | ||
| 6-month return | -22.2% | ||
| 12-month return, skipping the last month | -28.5% | ||
| Stability (higher is calmer) | 51 · Fair | Typical risk for this exchange. | |
| Volatility, 1 year (lower is calmer) | 30.6% | ||
| Worst drawdown, 1 year (smaller is calmer) | -37.1% | ||
| Liquidity | 74 · Strong | Trades actively. | |
| Average daily value traded | 1.23M EUR | ||
| Zero-volume days | 0.0% | ||
| Income | 62 · Fair | Dividend is typical for this exchange. | |
| Dividend yield | 4.2% | ||
| Years with dividends | 5 |
Strengths
- Liquidity: Trades actively.
Weak spots
- Trend: Below its long-term averages and far from its highs.
- Momentum: Lagging most stocks on this exchange.
Returns
| 1 week | −3.7% |
|---|---|
| 1 month | −9.5% |
| 3 months | −14.6% |
| 6 months | −22.2% |
| 1 year | −35.2% |
| 3 years | −45.1% |
| 5 years | −65.9% |
Signals
| 50-day / 200-day average | 10.892 / 12.359 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 0.278 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 27 Apr 2026 | EUR 0.4200 |
| 8 May 2025 | EUR 0.4000 |
| 2 May 2024 | EUR 0.4700 |
| 17 May 2023 | EUR 0.4500 |
| 26 May 2022 | EUR 0.5100 |
| 30 Jul 2021 | EUR 0.2600 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on XETRA Stock Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.